- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
An analysis of the stock market impact of material weakness disclosures, provided by Compliance Week subscriber Dan Spiegelman, SVP and CFO of Palo Alto based CV Therapeutics.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
In this session we will discuss the current state of financial and nonfinancial reporting and recent survey findings from Workiva about how attitudes on integrated reporting are evolving.
A Nevada energy and manufacturing company headquartered in Nova Scotia agreed to pay $1 million to settle charges levied by the Securities and Exchange Commission for alleged market manipulation and fraud, while the agency further investigates its former chief executives.
This presentation will provide an overview of the key provisions of DORA and their implications for Third-Party Risk Management (TPRM) teams, list best practices for DORA preparation and review key considerations for teams looking to implement the DORA framework.
No comments yet